Big Health
Big Health develops digital therapeutics for mental health, most prominently Sleepio for insomnia (based on cognitive behavioural therapy) and Daylight for anxiety. Its prescription product SleepioRx received FDA clearance in 2024. The company is dual-based in San Francisco and London.
- Founded
- 2010
- Headquarters
- San Francisco, California, US and London, UK
- Founders
- Peter Hames, Colin Espie
- Status
- Private
- Latest round
- Series C, $75M (2021)
- Key investors
- SoftBank Vision Fund 2, Index Ventures
- Category
- Digital therapeutics
- Products
- Sleepio, SleepioRx, Daylight, SparkRx
- Website
- www.bighealth.com
Covered in: Digital Therapeutics
Profile compiled from the public sources listed above. Funding, valuation, and employee figures are point-in-time and may be out of date.